高血压合并肌少症的发病机制及药物治疗的研究进展
Research Progress on Pathogenesis and Drug Treatment of Hypertension Complicated with Sarcopenia
DOI: 10.12677/ACM.2022.125599, PDF,   
作者: 张晓琼*：青海大学研究生院，青海 西宁；左小芹#：青海大学附属医院老年科，青海 西宁
关键词: 高血压；肌少症；发病机制；药物治疗；Hypertension； Sarcopenia； Pathogenesis； Drug Therapy
摘要: 高血压是一种以体循环动脉血压增高为主要特征，可伴发心、脑、肾等器官功能或器质性损害的临床综合性疾病，也是老年人较为常见的慢性疾病之一，肌少症是一种增龄性的老年综合征，以全身性肌肉力量、质量下降和机体功能减退为主要表现，与临床不良结局相关。两者常合并存在且相互影响。本文将对两者的发病机制及治疗进行综述，旨在为临床诊疗提供科学依据。
Abstract: High blood pressure is a kind of systemic arterial blood pressure as the main characteristics, with the heart, brain, kidney and other organs function or organic damage of clinical comprehensive disease, is one of the more common in the elderly with chronic disease, sarcopenia is a kind of senile syndrome, with systemic muscle strength, lower quality and reduced the body function as the main performance, is associated with poor clinical outcomes. The two often exist together and influence each other. This article will review the pathogenesis and treatment of the two diseases, in order to provide scientific basis for clinical diagnosis and treatment.
文章引用：张晓琼, 左小芹. 高血压合并肌少症的发病机制及药物治疗的研究进展[J]. 临床医学进展, 2022, 12(5): 4132-4136. https://doi.org/10.12677/ACM.2022.125599

参考文献

[1] 李苏宁, 陈祚, 王增武, 等. 我国老年人高血压现状分析[J]. 中华高血压杂志, 2019, 27(2): 140-148.
[2] Xie, X., He, T., Kang, J., et al. (2018) Cost-Effectiveness Analysis of Intensive Hypertension Control in China. Preventive Medi-cine, 111, 110-114. [Google Scholar] [CrossRef] [PubMed]
[3] Kitamura, A., Seino, S., Abe, T., et al. (2021) Sarcopenia: Prevalence, Associated Factors, and the Risk of Mortality and Disability in Japanese Older Adults. Journal of Cachexia, Sarcopenia and Muscle, 12, 30-38. [Google Scholar] [CrossRef] [PubMed]
[4] Choo, Y.J. and Chang, M.C. (2021) Prevalence of Sarcopenia among the Elderly in Korea: A Meta-Analysis. Journal of Preventive Medicine and Public Health, 54, 96-102. [Google Scholar] [CrossRef] [PubMed]
[5] 罗健, 张源明. 高血压: 一种慢性低级别炎症性疾病[J]. 心血管病学进展, 2010, 31(4): 567-569.
[6] Çoner, A., Gençtoy, G., Akinci, S., et al. (2019) Assessment of Vascular Inflam-mation and Subclinical Nephropathy in Exaggerated Blood Pressure Response to Exercise Test. Blood Pressure Moni-toring, 24, 114-119. [Google Scholar] [CrossRef] 
[7] Cortez, A. and Muxfeldt, E. (2022) Monocyte Chemoat-tractant Protein-1 and Hypertension: An Overview. Hipertensión y Riesgo Vascular, 39, 14-23. [Google Scholar] [CrossRef] [PubMed]
[8] Afandy, N.O., Lock, H.S., Tay, L., et al. (2021) Association of Monocyte Chemotactic Protein-1 and Dickkopf-1 with Body Composition and Physical Performance in Communi-ty-Dwelling Older Adults in Singapore. Journal of Frailty, Sarcopenia and Falls, 6, 25-31. [Google Scholar] [CrossRef] 
[9] Dikalova, A., Mayorov, V., Xiao, L., et al. (2020) Mitochondrial Iso-levuglandins Contribute to Vascular Oxidative Stress and Mitochondria-Targeted Scavenger of Isolevuglandins Reduces Mitochondrial Dysfunction and Hypertension. Hypertension, 76, 1980-1991. [Google Scholar] [CrossRef] 
[10] Griendling, K.K., Camargo, L.L., Rios, F.J., et al. (2021) Oxidative Stress and Hypertension. Circulation Research, 128, 993-1020. [Google Scholar] [CrossRef] 
[11] Dikalov, S.I. and Dikalova, A.E. (2019) Crosstalk be-tween Mitochondrial Hyperacetylation and Oxidative Stress in Vascular Dysfunction and Hypertension. Antioxidants & Redox Signaling, 31, 710-721. [Google Scholar] [CrossRef] [PubMed]
[12] Semba, R.D., Moaddel, R., Zhang, P., et al. (2019) Tetra-Linoleoyl Cardiolipin Depletion Plays a Major Role in the Pathogenesis of Sarcopenia. Medical Hypotheses, 127, 142-149. [Google Scholar] [CrossRef] [PubMed]
[13] Jiang, Y., Ye, J., Zhao, M., et al. (2018) Cross-Sectional and Longitudinal Associations between Serum Testosterone Concentrations and Hypertension: Results from the Fangcheng-gang Area Male Health and Examination Survey in China. Clinica Chimica Acta, 487, 90-95. [Google Scholar] [CrossRef] [PubMed]
[14] Feldman, H.A., Longcope, C., Derby, C.A., et al. (2002) Age Trends in the Level of Serum Testosterone and Other Hormones in Middle-Aged Men: Longitudinal Results from the Massachusetts Male Aging Study. The Journal of Clinical Endocrinology & Metabolism, 87, 589-598. [Google Scholar] [CrossRef] [PubMed]
[15] Sarkar, M., VanWagner, L.B., Terry, J.G., et al. (2019) Sex Hor-mone-Binding Globulin Levels in Young Men Are Associated with Nonalcoholic Fatty Liver Disease in Midlife. The American Journal of Gastroenterology, 114, 758-763. [Google Scholar] [CrossRef] [PubMed]
[16] 詹莹莹, 陈锐, 刘琳妍, 等. 肌少症与慢性心力衰竭的相关研究进展[J]. 实用老年医学, 2021, 35(7): 758-761.
[17] 区大刚, 张栋武, 解绪红, 等. 胰岛素样生长因子1及25羟基维生素D与女性原发性高血压病的再研究[J]. 中国医学创新, 2018, 15(20): 15-19.
[18] Horio, T., Kamide, K., Kawano, Y., et al. (2010) Association of Insulin-Like Growth Factor-1 Receptor Gene Polymorphisms with Left Ventricular Mass and Geometry in Essential Hypertension. Journal of Human Hypertension, 24, 320-326. [Google Scholar] [CrossRef] [PubMed]
[19] Vecchione, C., Colella, S., Fratta, L., et al. (2001) Impaired Insulin-Like Growth Factor I Vasorelaxant Effects in Hypertension. Hypertension, 37, 1480-1485. [Google Scholar] [CrossRef] 
[20] Cooper, S.A., Whaley-Connell, A., Habibi, J., Wei, Y.Z., et al. (2007) Renin-Angiotensin-Aldosterone System and Oxidative Stress in Cardiovascular Insulin Resistance. The American Journal of Physiology-Heart and Circulatory Physiology, 293, H2009-H2023. [Google Scholar] [CrossRef] [PubMed]
[21] Jarmusch, S., Baber, L., Bidlingmaier, M., et al. (2021) Influence of IGF-I Serum Concentration on Muscular Regeneration Capacity in Patients with Sarcopenia. BMC Musculoskeletal Disorders, 22, Article No. 807. [Google Scholar] [CrossRef] [PubMed]
[22] Caulfield, L., Heslop, P., Walesby, K.E., et al. (2021) Effect of Angiotensin System Inhibitors on Physical Performance in Older People—A Systematic Review and Meta-Analysis. Journal of the American Medical Directors Association, 22, 1215-1221. [Google Scholar] [CrossRef] [PubMed]
[23] Sumukadas, D., Witham, M.D., Struthers, A.D., et al. (2007) Ef-fect of Perindopril on Physical Function in Elderly People with Functional Impairment: A Randomized Controlled Trial. Canadian Medical Association Journal, 177, 867-874. [Google Scholar] [CrossRef] [PubMed]
[24] Composition, S., et al. (1998) Improved Exercise Tolerance After Losar-tan and Enalapril in Heart Failure. Fine Japanese Prints, 98, 1742-1749. [Google Scholar] [CrossRef] 
[25] Onder, G., Penninx, B.W., Balkrishnan, R., Fried, L.P., et al. (2002) Relation between Use of Angiotensin-Converting Enzyme Inhibitors and Muscle Strength and Physical Function in Older Women: An Observational Study. The Lancet, 359, 926-930. [Google Scholar] [CrossRef] 
[26] Witham, M.D., Syddall, H.E., Dennison, E., et al. (2014) ACE Inhibitors, Statins and Thiazides: No Association with Change in Grip Strength among Community Dwelling Older Men and Women from the Hertfordshire Cohort Study. Age Ageing, 43, 661-666. [Google Scholar] [CrossRef] [PubMed]

为你推荐